Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Torularhodin, isolated from Sporidiobolus pararoseus, inhibits human prostate cancer LNCaP and PC-3 cell growth through Bcl-2/Bax mediated apoptosis and AR down-regulation
Chao Dua,
Yingchao Lia,
Yahui Guoa,
Mei Hanc,
Weiguo Zhangc and
He Qian*ab
aSchool of Food Science and Technology, Jiangnan University, 1800 Lihu Avenue Wuxi, Jiangsu Province 214122, P. R. China. E-mail: amtf168168@126.com; Fax: +86-510-8532 9081; Tel: +86-510-8532 8713
bNational Engineering Research Center for Functional Food, Jiangnan University, 1800 Lihu Avenue Wuxi, Jiangsu Province 214122, P. R. China
cSchool of Biotechnology, Jiangnan University, 1800 Lihu Avenue Wuxi, Jiangsu Province 214122, P. R. China. E-mail: hanmei.918521@163.com
First published on 26th January 2016
Abstract
Correction for ‘Torularhodin, isolated from Sporidiobolus pararoseus, inhibits human prostate cancer LNCaP and PC-3 cell growth through Bcl-2/Bax mediated apoptosis and AR down-regulation’ by Chao Du et al., RSC Adv., 2015, 5, 106387–106395.
In a couple of instances the compound torulene is incorrectly mentioned:
In Section 3.5 the sentence beginning “To determine the effects of torularhodin and torulene in the intracellular Ca2+ level, …” should read “To determine the effect of torularhodin in the intracellular Ca2+ level, …”. Also, in the legend to Fig. 5(B) the sentence beginning “(B) The effect of torulene on Bcl-2 protein expression…” should read “(B) The effect of torularhodin on Bcl-2 protein expression…”.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2016 |